BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 3957108)

  • 1. Quantitative and qualitative comparison of gall bladder mucus glycoprotein from patients with and without gall stones.
    Harvey PR; Rupar CA; Gallinger S; Petrunka CN; Strasberg SM
    Gut; 1986 Apr; 27(4):374-81. PubMed ID: 3957108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy.
    Rhodes M; Allen A; Dowling RH; Murphy G; Lennard TW
    Gut; 1992 Aug; 33(8):1113-7. PubMed ID: 1398238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
    Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
    Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intermittent secretion of abnormal bile in patients with cholesterol gall stones.
    Smallwood RA; Jablonski P; Watts JM
    Br Med J; 1972 Nov; 4(5835):263-6. PubMed ID: 5083887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nature and composition of biliary sludge.
    Lee SP; Nicholls JF
    Gastroenterology; 1986 Mar; 90(3):677-86. PubMed ID: 3943697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucus glycoprotein content of human cholesterol gallstones.
    Pearson JP; Foster SN
    Digestion; 1987; 36(3):132-40. PubMed ID: 3596075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biliary proteins and the nucleation defect in cholesterol cholelithiasis.
    Gallinger S; Harvey PR; Petrunka CN; Ilson RG; Strasberg SM
    Gastroenterology; 1987 Apr; 92(4):867-75. PubMed ID: 3556994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total biliary protein, mucus glycoproteins, cyclic-AMP, and apolipoproteins in the gallbladder bile of patients with cholesterol stones and stone-free controls.
    Swobodnik W; Wenk H; Janowitz P; Hagert N; Kratzer W; Berghold J; Zhang Y; Bittner R; Schusdziarra V; Ott R
    Scand J Gastroenterol; 1991 Jul; 26(7):771-8. PubMed ID: 1654593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucus glycoprotein biosynthesis in the human gall bladder: inhibition by aspirin.
    Rhodes M; Allen A; Lennard TW
    Gut; 1992 Aug; 33(8):1109-12. PubMed ID: 1398237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease.
    Groen AK; Noordam C; Drapers JA; Egbers P; Jansen PL; Tytgat GN
    Hepatology; 1990 Apr; 11(4):525-33. PubMed ID: 2328950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleation time of gall bladder bile in gall stone patients: influence of bile acid treatment.
    Sahlin S; Ahlberg J; Angelin B; Reihnér E; Einarsson K
    Gut; 1991 Dec; 32(12):1554-7. PubMed ID: 1773966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.
    Lanzini A; Northfield TC
    Gut; 1990 Feb; 31(2):226-30. PubMed ID: 2311984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gall bladder bile and endoscopically obtained duodenal bile.
    Janowitz P; Swobodnik W; Wechsler JG; Zöller A; Kuhn K; Ditschuneit H
    Gut; 1990 Dec; 31(12):1407-10. PubMed ID: 2265783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbohydrate moieties of glycoproteins in human hepatic and gall-bladder bile, gall-bladder mucosa and gall stones.
    Lee SP; Lim TH; Scott AJ
    Clin Sci (Lond); 1979 Jan; 56(6):533-8. PubMed ID: 477239
    [No Abstract]   [Full Text] [Related]  

  • 15. Gallbladder function, cholesterol stones, and bile composition.
    Antsaklis G; Lewin MR; Sutor DJ; Cowie AG; Clark CG
    Gut; 1975 Dec; 16(12):937-42. PubMed ID: 1218816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gall stone disease without gall stones--bile acid and bile lipid metabolism after complete gall stone dissolution.
    Ruppin DC; Murphy GM; Dowling RH
    Gut; 1986 May; 27(5):559-66. PubMed ID: 3699565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of binding of ionised calcium on the in vitro nucleation of cholesterol and calcium bilirubinate in human gall bladder bile.
    Gallinger S; Harvey PR; Petrunka CN; Strasberg SM
    Gut; 1986 Nov; 27(11):1382-6. PubMed ID: 3098634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones.
    Sahlin S; Ahlberg J; Einarsson K; Henriksson R; Danielsson A
    Gut; 1990 Jan; 31(1):100-5. PubMed ID: 2318423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
    Sahlin S; Danielsson A; Angelin B; Reihnér E; Henriksson R; Einarsson K
    Gut; 1988 Nov; 29(11):1506-10. PubMed ID: 3209106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of mucin in the hepatic bile of patients with intrahepatic pigment stones.
    Yamasaki T; Nakayama F; Tamura S; Endo M
    J Gastroenterol Hepatol; 1992; 7(1):36-41. PubMed ID: 1543865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.